跳至主要内容
临床试验/ITMCTR1900002644
ITMCTR1900002644尚未招募1 期

A Multicenter, Randomized and Controlled Trial for Chang-An-Jun-Tai Granule in the Treatment of Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D).

The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • To simultaneously satisfy the following criteria:
  • 1. Conform to the Roman IV(Rome IV) of a patient diagnosed with IBS-D and baseline IBS-SSS score > 75;
  • 2. Aged 18 to 60 years;
  • 3. Nearly 2 weeks no using the drugs in the treatment of IBS;
  • 4. Nearly 2 weeks no using antibiotics or probiotics;
  • 5. The patients volunteered to receive the drug and signed an informed consent form, and the informed consent process was in accordance with the relevant provisions of GCP.

排除标准

  • Meet one of the following criteria were excluded:
  • 1. there is explanation above the clinical symptoms of the patients with other diseases;
  • 2. chronic esophagitis, Barrett esophagus and gastroesophageal reflux disease, peptic ulcer, gastric polyp (without resection), digestive tract tumor patients;
  • 3. found that endoscopic gastric mucosa high grade intraepithelial neoplasia, pathological diagnosis, malignant gastrointestinal organic diseases;
  • 4. patients with history of abdominal operation;
  • 5. allergic or allergic to many medicines;
  • 6. confusion, dementia, psychosis, neurosis and various serious unwilling to cooperate;
  • 7. with serious the primary cardiovascular disease, liver disease, kidney disease, blood disease, lung disease, autoimmune diseases, or serious diseases affected the survival, such as cancer or aids;
  • 8. pregnant and lactating women;
  • 9. exist cognitive or other damage (such as vision, etc.) and impact on the participants completed self-report;
  • 10. of the pharmaceutical composition ingredients allergies are; is or 4 weeks in other drug clinical trials of patients;
  • 11. investigators have sufficient reason to believe that the participants according to current medical or psychological state is not suitable for researchers to study.

研究者

发起方
The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine

相似试验

进行中(未招募)
不适用
Previous Study | Return to List | Next Study A Trial to Evaluate the Correlation Between Spontaneous Catch-up Growth, Clinical Response to Saizen (Recombinant Human Growth Hormone, r-hGH) and Gene Expression Profiling in Children Small for Gestational Age (SGA) (SAIZEN in SGA)Small for Gestational Age
EUCTR2015-001681-25-Outside-EU/EEAMerck KGaA25
招募中
4 期
A multicenter, randomized, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng injection in the treatment of novel coronavirus pneumonia (COVID-19)ovel Coronavirus Pneumonia (COVID-19)
ITMCTR2000003004nion Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
进行中(未招募)
不适用
A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts. - PRINS study
EUCTR2007-002763-27-NLErasmus MC
已完成
4 期
A multi-center, randomized, controlled trial with programmed introduction of Sirolimus-based, Calcineurin inhibitor free immunosuppression in recipients of non-heart-beating donor kidney grafts.kidney transplant function10038430
NL-OMON31753Erasmus MC, Universitair Medisch Centrum Rotterdam100
尚未招募
1 期
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high risk
ITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine